Learn More
Medchemexpress LLC Hydroxyflutamide | 52806-53-8 | 99.77% | 292.21 | 5 MG

Supplier: Medchemexpress LLC HYW0132725MG
Hydroxyflutamide (HFT) is the active metabolite of Flutamide (HY-B0022) and is orally active. It acts as a potent androgen receptor antagonist with an IC50 of 700 nM. This compound has been shown to affect embryonic development and reproductive tract development in mice. Additionally, Hydroxyflutamide can enhance the efficacy of Bacillus Calmette-Guérin (BCG) in inhibiting the progression of bladder cancer. It is suitable for research related to tumors and reproductive diseases.
- Active metabolite of Flutamide.
- Exhibits oral activity.
- Potent androgen receptor antagonist with an IC50 of 700 nM.
- Can affect embryonic development and reproductive tract development in mice.
- Enhances the efficacy of Bacillus Calmette-Guérin (BCG) to inhibit bladder cancer progression.
- Useful in research related to tumors and reproductive diseases.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.